BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  ResMed To Announce Second Quarter Fiscal Year 2017 Results

  December 20, 2016

   · 

  1 min read
• Policy

  HematoGenix Receives Accreditation From College of American Pathologists

  December 20, 2016

   · 

  2 min read
• Business

  Imperial Innovations Release: Portfolio Company PsiOxus Signs Exclusive Worldwide License Agreement With BMS For NG-348 Its First “Armed” Oncolytic Virus

  December 20, 2016

   · 

  2 min read
• Drug Development

  Juno’ And Celgene’s Investigational Drug JCAR017 Granted Breakthrough Therapy Designation From FDA And Priority Medicines Eligibility From EMAFor Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  December 20, 2016

   · 

  5 min read
• Bio NC

  RUBRACA (Rucaparib) Approved For The Treatment Of Advanced Ovarian Cancer, Available Immediately At Biologics

  December 20, 2016

   · 

  3 min read
• Business

  Symcel And Colzyx Partner To Test 25 Novel, First-In-Kind Collagen VI Derived Anti Microbial Peptides With calScreener

  December 20, 2016

   · 

  2 min read
• Pharm Country

  Elusys Therapeutics, Inc. Announces Publication Of Data Establishing The Adult Human Dose For Its Inhalational Anthrax Antitoxin, ANTHIM (obiltoxaximab) Injection

  December 20, 2016

   · 

  7 min read
• Business

  Royal Philips Electronics N.V. And CHRISTUS Health Expand Relationship With Enhanced Population Health Management Capabilities

  December 20, 2016

   · 

  5 min read
• Pharm Country

  Albert Einstein College of Medicine Receives Major Federal Grant For Research Into Intellectual And Developmental Disabilities

  December 20, 2016

   · 

  5 min read
• Business

  X-Chem Announces Multi-Target Drug Discovery Collaboration With Taiho Pharma Using DEX Technology

  December 20, 2016

   · 

  4 min read